FDA recall,
Breckenridge Pharmaceutical, Inc. Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg
Propranolol Hydrochloride Extended-Release Capsules have potential metal contamination.
2 photos
What to do
Check yoursIf a code on your package is listed below:
- Immediately stop taking product from the lot subject to this recall and contact your physician or healthcare provider for medical advice and replacement instructions.
- Return any unused portion of the affected product to the pharmacy where it was obtained.
- Contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this product.
- Entities that further distributed the product should notify their sub-accounts to the retail level.
For stores and distributors: Wholesalers, pharmacies, and other retail entities should check inventory for the recalled lot, quarantine any affected product, and not distribute or dispense the affected product.
What happened
Breckenridge Pharmaceutical, Inc. is voluntarily recalling one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, due to potential metal contamination. The recall reaches down to the people who have the product. The company said use of product from the affected lot could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine. To date, Breckenridge is not aware of any adverse events related to this recall.
The affected lot shared intermediate material suspected to be the source of metal contamination found in a separate lot that was not released to market. The product was manufactured by Adare Pharma Solutions. It was distributed nationwide to wholesalers and pharmacies between October 26, 2026 and November 04, 2026. The company announced the recall on November 16, 2026.
Is your bottle affected?
Match the lot code, best-by or expiration date and NDC listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg
- Size
- 100-count bottle
- NDC
- 51991-817-01
- Lot code
- PK25110035
- Best-by or expiration date
- May 2029
Recall details
- Company announced
- Weekly archive
- Listed the week of Nov 16, 2026
- Sold in
Product from the affected lot subject to this recall was distributed nationwide to wholesalers and pharmacies between October 26, 2026 and November 04, 2026.
- Recalled by
- Breckenridge Pharmaceutical, Inc.
- Hazard
- Contamination · Foreign object



